Literature DB >> 21719738

Ostα depletion protects liver from oral bile acid load.

Carol J Soroka1, Heino Velazquez, Albert Mennone, Nazzareno Ballatori, James L Boyer.   

Abstract

Bile acid homeostasis is tightly maintained through interactions between the liver, intestine, and kidney. During cholestasis, the liver is incapable of properly clearing bile acids from the circulation, and alternative excretory pathways are utilized. In obstructive cholestasis, urinary elimination is often increased, and this pathway is further enhanced after bile duct ligation in mice that are genetically deficient in the heteromeric, basolateral organic solute transporter alpha-beta (Ostα-Ostβ). In this study, we examined renal and intestinal function in Ostα-deficient and wild-type mice in a model of bile acid overload. After 1% cholic acid feeding, Ostα-deficient mice had significantly lower serum ALT levels compared with wild-type controls, indicating partial protection from liver injury. Urinary clearance of bile acids, but not clearance of [(3)H]inulin, was significantly higher in cholic acid-fed Ostα-deficient mice compared with wild-type mice but was not sufficient to account for the protection. Fecal excretion of bile acids over the 5 days of cholic acid feeding was responsible for almost all of the bile acid loss in Ostα-deficient mice, suggesting that intestinal losses of bile acids accounted for the protection from liver injury. Thus fecal loss of bile acids after bile acid overload reduced the need for the kidney to filter and excrete the excess bile acids. In conclusion, Ostα-deficient mice efficiently eliminate excess bile acids via the feces. Inhibition of intestinal bile acid absorption might be an effective therapeutic target in early stages of cholestasis when bile acids are still excreted into bile.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21719738      PMCID: PMC3174539          DOI: 10.1152/ajpgi.00141.2011

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  18 in total

Review 1.  New perspectives for the treatment of cholestasis: lessons from basic science applied clinically.

Authors:  James L Boyer
Journal:  J Hepatol       Date:  2006-12-18       Impact factor: 25.083

2.  Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter.

Authors:  A L Craddock; M W Love; R W Daniel; L C Kirby; H C Walters; M H Wong; P A Dawson
Journal:  Am J Physiol       Date:  1998-01

3.  Comparative analysis of the ontogeny of a sodium-dependent bile acid transporter in rat kidney and ileum.

Authors:  D M Christie; P A Dawson; S Thevananther; B L Shneider
Journal:  Am J Physiol       Date:  1996-08

4.  Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents.

Authors:  James L Boyer; Michael Trauner; Albert Mennone; Carol J Soroka; Shi-Ying Cai; Tarek Moustafa; Gernot Zollner; Jin Young Lee; Nazzareno Ballatori
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-01-19       Impact factor: 4.052

Review 5.  Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations.

Authors:  Gernot Zollner; Hanns-Ulrich Marschall; Martin Wagner; Michael Trauner
Journal:  Mol Pharm       Date:  2006 May-Jun       Impact factor: 4.939

6.  FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption.

Authors:  Diana Jung; Takeshi Inagaki; Robert D Gerard; Paul A Dawson; Steven A Kliewer; David J Mangelsdorf; Antonio Moschetta
Journal:  J Lipid Res       Date:  2007-09-06       Impact factor: 5.922

7.  The organic solute transporter alpha-beta, Ostalpha-Ostbeta, is essential for intestinal bile acid transport and homeostasis.

Authors:  Anuradha Rao; Jamie Haywood; Ann L Craddock; Martin G Belinsky; Gary D Kruh; Paul A Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-21       Impact factor: 11.205

8.  Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine.

Authors:  Insook Kim; Sung-Hoon Ahn; Takeshi Inagaki; Mihwa Choi; Shinji Ito; Grace L Guo; Steven A Kliewer; Frank J Gonzalez
Journal:  J Lipid Res       Date:  2007-08-24       Impact factor: 5.922

9.  Adaptive responses of renal organic anion transporter 3 (OAT3) during cholestasis.

Authors:  Jiarong Chen; Tomohiro Terada; Ken Ogasawara; Toshiya Katsura; Ken-ichi Inui
Journal:  Am J Physiol Renal Physiol       Date:  2008-05-14

10.  Heterodimerization, trafficking and membrane topology of the two proteins, Ost alpha and Ost beta, that constitute the organic solute and steroid transporter.

Authors:  Na Li; Zhifeng Cui; Fang Fang; Jin Young Lee; Nazzareno Ballatori
Journal:  Biochem J       Date:  2007-11-01       Impact factor: 3.857

View more
  14 in total

1.  Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid-fed mouse model of cholestasis.

Authors:  Supriya R Kulkarni; Carol J Soroka; Lee R Hagey; James L Boyer
Journal:  Hepatology       Date:  2016-10-28       Impact factor: 17.425

2.  Oral administration of oleanolic acid, isolated from Swertia mussotii Franch, attenuates liver injury, inflammation, and cholestasis in bile duct-ligated rats.

Authors:  Jin Chai; Xiaohuang Du; Sheng Chen; XinChan Feng; Ying Cheng; Liangjun Zhang; Yu Gao; Shaoxue Li; Xiaochong He; Rongquan Wang; Xiangdong Zhou; Yong Yang; Weizao Luo; Wensheng Chen
Journal:  Int J Clin Exp Med       Date:  2015-02-15

3.  Will the real bile acid sulfotransferase please stand up? Identification of Sult2a8 as a major hepatic bile acid sulfonating enzyme in mice.

Authors:  Paul A Dawson; Kenneth D R Setchell
Journal:  J Lipid Res       Date:  2017-04-28       Impact factor: 5.922

4.  Ostα-/- mice exhibit altered expression of intestinal lipid absorption genes, resistance to age-related weight gain, and modestly improved insulin sensitivity.

Authors:  Sadie G Wheeler; Christine L Hammond; François R Jornayvaz; Varman T Samuel; Gerald I Shulman; Carol J Soroka; James L Boyer; Patricia M Hinkle; Nazzareno Ballatori
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-12-31       Impact factor: 4.052

Review 5.  Animal models to study bile acid metabolism.

Authors:  Jianing Li; Paul A Dawson
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-05-18       Impact factor: 5.187

6.  Mouse organic solute transporter alpha deficiency alters FGF15 expression and bile acid metabolism.

Authors:  Tian Lan; Anuradha Rao; Jamie Haywood; Nancy D Kock; Paul A Dawson
Journal:  J Hepatol       Date:  2012-04-25       Impact factor: 25.083

Review 7.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  The heteromeric organic solute transporter, OSTα-OSTβ/SLC51: a transporter for steroid-derived molecules.

Authors:  Nazzareno Ballatori; Whitney V Christian; Sadie G Wheeler; Christine L Hammond
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

Review 9.  The solute carrier family 10 (SLC10): beyond bile acid transport.

Authors:  Tatiana Claro da Silva; James E Polli; Peter W Swaan
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

Review 10.  Targeting the Four Pillars of Enterohepatic Bile Salt Cycling; Lessons From Genetics and Pharmacology.

Authors:  Roni F Kunst; Henkjan J Verkade; Ronald P J Oude Elferink; Stan F J van de Graaf
Journal:  Hepatology       Date:  2021-05-24       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.